These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8520725)

  • 21. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil.
    Moser HW; Raymond GV; Lu SE; Muenz LR; Moser AB; Xu J; Jones RO; Loes DJ; Melhem ER; Dubey P; Bezman L; Brereton NH; Odone A
    Arch Neurol; 2005 Jul; 62(7):1073-80. PubMed ID: 16009761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.
    Aubourg P; Adamsbaum C; Lavallard-Rousseau MC; Rocchiccioli F; Cartier N; Jambaqué I; Jakobezak C; Lemaitre A; Boureau F; Wolf C
    N Engl J Med; 1993 Sep; 329(11):745-52. PubMed ID: 8350883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary management of X-linked adrenoleukodystrophy.
    Moser HW; Borel J
    Annu Rev Nutr; 1995; 15():379-97. PubMed ID: 8527226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary treatment for X-linked adrenoleukodystrophy: is "Lorenzo's oil" useful?
    Prieto Tenreiro A; Penacho Lázaro MÁ; Andrés Celda R; Fernández Fernández M; González Mateo C; Díez Hernández A
    Endocrinol Nutr; 2013 Jan; 60(1):37-9. PubMed ID: 22622158
    [No Abstract]   [Full Text] [Related]  

  • 25. Lorenzo's oil may help to prevent ALD symptoms.
    Senior K
    Lancet Neurol; 2002 Dec; 1(8):468. PubMed ID: 12849323
    [No Abstract]   [Full Text] [Related]  

  • 26. [Adrenoleukodystrophy: Lorenzo's Oil].
    Yamawaki T
    Brain Nerve; 2022 Dec; 74(12):1354-1357. PubMed ID: 36503132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy.
    Moser HW; Moser AB; Hollandsworth K; Brereton NH; Raymond GV
    J Mol Neurosci; 2007 Sep; 33(1):105-13. PubMed ID: 17901554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenoleukodystrophy and the mitochondrial connection: clues for supplementing Lorenzo's oil.
    Moraes CT
    Brain; 2013 Aug; 136(Pt 8):2339-41. PubMed ID: 23842565
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of erucic acid on platelets in patients with adrenoleukodystrophy.
    Kickler TS; Zinkham WH; Moser A; Shankroff J; Borel J; Moser H
    Biochem Mol Med; 1996 Apr; 57(2):125-33. PubMed ID: 8733890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A model-based approach to assess the exposure-response relationship of Lorenzo's oil in adrenoleukodystrophy.
    Ahmed MA; Kartha RV; Brundage RC; Cloyd J; Basu C; Carlin BP; Jones RO; Moser AB; Fatemi A; Raymond GV
    Br J Clin Pharmacol; 2016 Jun; 81(6):1058-66. PubMed ID: 26836218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.
    van Geel BM; Assies J; Wanders RJ; Barth PG
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):4-14. PubMed ID: 9221959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.
    Poulos A; Gibson R; Sharp P; Beckman K; Grattan-Smith P
    Ann Neurol; 1994 Nov; 36(5):741-6. PubMed ID: 7979219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is subclinical adrenal failure in adrenoleukodystrophy/adrenomyeloneuropathy reversible?
    Cappa M; Bizzarri C; Giannone G; Aiello C; Di Biase A
    J Endocrinol Invest; 2011 Nov; 34(10):753-6. PubMed ID: 21399389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive effects with Lorenzo's oil.
    Siva N
    Lancet Neurol; 2005 Sep; 4(9):529. PubMed ID: 16136703
    [No Abstract]   [Full Text] [Related]  

  • 35. Adrenoleukodystrophy: a link between adrenal insufficiency and school performance.
    Bakos JT; Goen P; Ogden A; Brown FR; Karaviti LP
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2869-72. PubMed ID: 7559867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and therapeutic aspects of adrenoleukodystrophy and adrenomyeloneuropathy.
    Moser HW
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):740-5. PubMed ID: 7666063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bleeding in a patient taking Lorenzo's oil: evidence for a vascular defect.
    Chai BC; Etches WS; Stewart MW; Siminoski K
    Postgrad Med J; 1996 Feb; 72(844):113-4. PubMed ID: 8871463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adrenoleukodystrophy].
    Kálmánchey R; Molzer B; Illés Z; Princzinger A; Sólyom J
    Orv Hetil; 1997 Apr; 138(14):867-71. PubMed ID: 9162896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring of very long-chain fatty acids levels in X-linked adrenoleukodystrophy, treated with haematopoietic stem cell transplantation and Lorenzo's Oil.
    Stradomska TJ; Drabko K; Moszczyńska E; Tylki-Szymańska A
    Folia Neuropathol; 2014; 52(2):159-63. PubMed ID: 25118901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hexacosanoic and docosanoic acids plasma levels in patients with cerebral childhood and asymptomatic X-linked adrenoleukodystrophy: Lorenzo's oil effect.
    Deon M; Garcia MP; Sitta A; Barschak AG; Coelho DM; Schimit GO; Pigatto M; Jardim LB; Wajner M; Giugliani R; Vargas CR
    Metab Brain Dis; 2008 Mar; 23(1):43-9. PubMed ID: 18026827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.